AI
RLYB icon

Allostery Investments’s Rallybio RLYB Stock Holding History

Allostery Investments’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-94,029
Closed -$492K – 37
2025
Q1 		$492K Sell
94,029
-6,396
-6% -$40.4K 0.71% 29
2024
Q4 		$771K Buy
+100,425
New +$841K 0.81% 22

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return

Allostery Investments's RLYB Position: Q2 2025 in Review

Allostery Investments sold out of Rallybio (RLYB) in Q2 2025, closing a stake of 94,029 shares — an estimated $492K sold.

Allostery Investments first reported a position in RLYB in Q4 2024 and held it in 2 quarters. The position peaked at $771K in Q4 2024. 48 funds tracked by Wall St. Rank hold RLYB as of Q2 2025.

  • Allostery Investments reported no remaining Rallybio position as of Q2 2025 after selling out during the quarter.
  • Allostery Investments sold 94,029 Rallybio shares in Q2 2025, an estimated $492K.
  • Allostery Investments first reported a position in Rallybio in Q4 2024 and held it in 2 quarters.
  • Allostery Investments's Rallybio position peaked at $771K in Q4 2024.
  • 48 funds tracked by Wall St. Rank held Rallybio as of Q2 2025.

Based on Allostery Investments's 13F filing for Q2 2025, filed 14 Aug 2025.